Travoprost – a new prostaglandin analogue for the treatment of glaucoma

Author： Whitson Jess T  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.7, 2002-07, pp. : 965-977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostaglandin Analogues in the Treatment of Glaucoma

By Lindén C.  

Drugs & Aging, Vol. 14, Iss. 5, 1999-05 ,pp. : 387-398

Adis International

Access to resources Recommend Favorite

Travoprost looks best for the budget in glaucoma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Assessment of the Cost Effectiveness of Travoprost versus Latanoprost as Single Agents for Treatment of Glaucoma in France

By Payet Stéphanie  

Clinical Drug Investigation, Vol. 28, Iss. 3, 2008-01 ,pp. : 183-198

Adis International

Access to resources Recommend Favorite

Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence

By Orme Michelle   Boler Annabel  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 743-750

Adis International

Access to resources Recommend Favorite

Travoprost/timolol looks to be cost saving in glaucoma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite